Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous tranexamic acid for blood loss reduction in endoscopic endonasal transsphenoidal pituitary surgery
TCTR20260913004Phase 4Not yet recruiting
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in pituitary adenoma, sponsored by King Chulalongkorn Memorial Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
pituitary adenoma
Beyond the preview
Go deeper on TCTR20260913004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260913004.